Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)

Silvia Pecere, Grainne Holleran, Maria Elena Ainora, Matteo Garcovich, Franco Scaldaferri, Antonio Gasbarrini, Maria Assunta Zocco

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Intestinal ultrasonography has emerged as a cheap, non-invasive and readily accessible modality for the assessment of a number of gastroenterological diseases. Over the last decade, particularly due to the widespread use of biological agents in Inflammatory Bowel Disease (IBD), guidelines regarding management and follow-up advise more regular disease assessment and surveillance in order to guide treatment adjustments, and provide more personalised care. Given the young age of the majority of patients with IBD the availability of an alternative modality to harmful radiation or the risks of endoscopy for this indication offers an appealing advantage. Intestinal ultrasonography has been shown to be as sensitive and specific for detecting IBD as both computed tomography and magnetic resonance enterography, and endoscopic evaluation. More recent developments in the technology of ultrasonography equipment and the use of intravenous contrast agents (contrast enhanced ultrasonography, known as CEUS), have significantly increased the ability to both detect disease location, determine the disease activity and also potentially the difference between fibrotic and inflammatory segments. This review focusses specifically on the value of CEUS for the diagnosis of both Crohn's disease and Ulcerative Colitis, in determining disease activity, extraintestinal complications, determination of fibrosis as well as its more recent use in assessing and predicting response to biological and immunosuppressive therapies.

Original languageEnglish
Pages (from-to)761-767
Number of pages7
JournalDigestive and Liver Disease
Volume50
Issue number8
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Inflammatory Bowel Diseases
Ultrasonography
Biological Therapy
Biological Factors
Immunosuppressive Agents
Ulcerative Colitis
Crohn Disease
Contrast Media
Endoscopy
Fibrosis
Magnetic Resonance Spectroscopy
Tomography
Guidelines
Radiation
Technology
Equipment and Supplies
Therapeutics

Keywords

  • Contrast enhanced ultrasonography
  • Crohn's disease activity index
  • Inflammatory Bowel Disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). / Pecere, Silvia; Holleran, Grainne; Ainora, Maria Elena; Garcovich, Matteo; Scaldaferri, Franco; Gasbarrini, Antonio; Zocco, Maria Assunta.

In: Digestive and Liver Disease, Vol. 50, No. 8, 01.08.2018, p. 761-767.

Research output: Contribution to journalReview article

@article{be7d3af1b3be45a5907262c2efc7946e,
title = "Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)",
abstract = "Intestinal ultrasonography has emerged as a cheap, non-invasive and readily accessible modality for the assessment of a number of gastroenterological diseases. Over the last decade, particularly due to the widespread use of biological agents in Inflammatory Bowel Disease (IBD), guidelines regarding management and follow-up advise more regular disease assessment and surveillance in order to guide treatment adjustments, and provide more personalised care. Given the young age of the majority of patients with IBD the availability of an alternative modality to harmful radiation or the risks of endoscopy for this indication offers an appealing advantage. Intestinal ultrasonography has been shown to be as sensitive and specific for detecting IBD as both computed tomography and magnetic resonance enterography, and endoscopic evaluation. More recent developments in the technology of ultrasonography equipment and the use of intravenous contrast agents (contrast enhanced ultrasonography, known as CEUS), have significantly increased the ability to both detect disease location, determine the disease activity and also potentially the difference between fibrotic and inflammatory segments. This review focusses specifically on the value of CEUS for the diagnosis of both Crohn's disease and Ulcerative Colitis, in determining disease activity, extraintestinal complications, determination of fibrosis as well as its more recent use in assessing and predicting response to biological and immunosuppressive therapies.",
keywords = "Contrast enhanced ultrasonography, Crohn's disease activity index, Inflammatory Bowel Disease",
author = "Silvia Pecere and Grainne Holleran and Ainora, {Maria Elena} and Matteo Garcovich and Franco Scaldaferri and Antonio Gasbarrini and Zocco, {Maria Assunta}",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.dld.2018.03.023",
language = "English",
volume = "50",
pages = "761--767",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "8",

}

TY - JOUR

T1 - Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)

AU - Pecere, Silvia

AU - Holleran, Grainne

AU - Ainora, Maria Elena

AU - Garcovich, Matteo

AU - Scaldaferri, Franco

AU - Gasbarrini, Antonio

AU - Zocco, Maria Assunta

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Intestinal ultrasonography has emerged as a cheap, non-invasive and readily accessible modality for the assessment of a number of gastroenterological diseases. Over the last decade, particularly due to the widespread use of biological agents in Inflammatory Bowel Disease (IBD), guidelines regarding management and follow-up advise more regular disease assessment and surveillance in order to guide treatment adjustments, and provide more personalised care. Given the young age of the majority of patients with IBD the availability of an alternative modality to harmful radiation or the risks of endoscopy for this indication offers an appealing advantage. Intestinal ultrasonography has been shown to be as sensitive and specific for detecting IBD as both computed tomography and magnetic resonance enterography, and endoscopic evaluation. More recent developments in the technology of ultrasonography equipment and the use of intravenous contrast agents (contrast enhanced ultrasonography, known as CEUS), have significantly increased the ability to both detect disease location, determine the disease activity and also potentially the difference between fibrotic and inflammatory segments. This review focusses specifically on the value of CEUS for the diagnosis of both Crohn's disease and Ulcerative Colitis, in determining disease activity, extraintestinal complications, determination of fibrosis as well as its more recent use in assessing and predicting response to biological and immunosuppressive therapies.

AB - Intestinal ultrasonography has emerged as a cheap, non-invasive and readily accessible modality for the assessment of a number of gastroenterological diseases. Over the last decade, particularly due to the widespread use of biological agents in Inflammatory Bowel Disease (IBD), guidelines regarding management and follow-up advise more regular disease assessment and surveillance in order to guide treatment adjustments, and provide more personalised care. Given the young age of the majority of patients with IBD the availability of an alternative modality to harmful radiation or the risks of endoscopy for this indication offers an appealing advantage. Intestinal ultrasonography has been shown to be as sensitive and specific for detecting IBD as both computed tomography and magnetic resonance enterography, and endoscopic evaluation. More recent developments in the technology of ultrasonography equipment and the use of intravenous contrast agents (contrast enhanced ultrasonography, known as CEUS), have significantly increased the ability to both detect disease location, determine the disease activity and also potentially the difference between fibrotic and inflammatory segments. This review focusses specifically on the value of CEUS for the diagnosis of both Crohn's disease and Ulcerative Colitis, in determining disease activity, extraintestinal complications, determination of fibrosis as well as its more recent use in assessing and predicting response to biological and immunosuppressive therapies.

KW - Contrast enhanced ultrasonography

KW - Crohn's disease activity index

KW - Inflammatory Bowel Disease

UR - http://www.scopus.com/inward/record.url?scp=85046154763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046154763&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2018.03.023

DO - 10.1016/j.dld.2018.03.023

M3 - Review article

C2 - 29705029

AN - SCOPUS:85046154763

VL - 50

SP - 761

EP - 767

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 8

ER -